ID PRDX4_MOUSE Reviewed; 274 AA. AC O08807; Q3U8E4; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1997, sequence version 1. DT 16-JUN-2009, entry version 89. DE RecName: Full=Peroxiredoxin-4; DE EC=1.11.1.15; DE AltName: Full=Prx-IV; DE AltName: Full=Thioredoxin peroxidase AO372; DE AltName: Full=Thioredoxin-dependent peroxide reductase A0372; DE AltName: Full=Antioxidant enzyme AOE372; GN Name=Prdx4; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; RX MEDLINE=21121079; PubMed=11229364; DOI=10.1089/15230860050192288; RA Wong C.M., Chun A.C., Kok K.H., Zhou Y., Fung P.C., Kung H.F., RA Jeang K.-T., Jin D.-Y.; RT "Characterization of human and mouse peroxiredoxin IV: evidence for RT inhibition by Prx-IV of epidermal growth factor- and p53-induced RT reactive oxygen species."; RL Antioxid. Redox Signal. 2:507-518(2000). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J, and DBA/2; TISSUE=Bone marrow, and Liver; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J, and NMRI; TISSUE=Mammary gland, and Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PROTEIN SEQUENCE OF 190-203 AND 216-226. RC STRAIN=C57BL/6; TISSUE=Brain; RA Lubec G., Kang S.U., Yang J.W., Zigmond M.; RL Submitted (JUL-2007) to UniProtKB. CC -!- FUNCTION: Probably involved in redox regulation of the cell. CC Regulates the activation of NF-kappa-B in the cytosol by a CC modulation of I-kappa-B-alpha phosphorylation. CC -!- CATALYTIC ACTIVITY: 2 R'-SH + ROOH = R'-S-S-R' + H(2)O + ROH. CC -!- SUBUNIT: Homodimer or heterodimer with PRDX1; disulfide-linked, CC upon oxidation. CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). CC -!- MISCELLANEOUS: The active site is the redox-active Cys-127 CC oxidized to Cys-SOH. Cys-SOH rapidly reacts with Cys-248-SH of the CC other subunit to form an intermolecular disulfide with a CC concomitant homodimer formation. The enzyme may be subsequently CC regenerated by reduction of the disulfide by thioredoxin (By CC similarity). CC -!- MISCELLANEOUS: Irreversibly inactivated by overoxidation of Cys- CC 127 (to Cys-SO(3)H) upon oxidative stress (By similarity). CC -!- SIMILARITY: Belongs to the ahpC/TSA family. CC -!- SIMILARITY: Contains 1 thioredoxin domain. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U96746; AAB57846.1; -; mRNA. DR EMBL; AK005031; BAB23758.1; -; mRNA. DR EMBL; AK146402; BAE27143.1; -; mRNA. DR EMBL; AK152255; BAE31074.1; -; mRNA. DR EMBL; BC003349; AAH03349.1; -; mRNA. DR EMBL; BC019578; AAH19578.1; -; mRNA. DR IPI; IPI00116254; -. DR RefSeq; NP_058044.1; -. DR UniGene; Mm.247542; -. DR HSSP; Q63716; 1QQ2. DR PeroxiBase; 4532; Mm2CysPrx04. DR PMMA-2DPAGE; O08807; -. DR REPRODUCTION-2DPAGE; O08807; -. DR PRIDE; O08807; -. DR Ensembl; ENSMUSG00000025289; Mus musculus. DR GeneID; 53381; -. DR KEGG; mmu:53381; -. DR NMPDR; fig|10090.3.peg.22366; -. DR MGI; MGI:1859815; Prdx4. DR HOGENOM; O08807; -. DR HOVERGEN; O08807; -. DR OMA; O08807; YLEEAGH. DR BRENDA; 1.11.1.15; 244. DR NextBio; 310209; -. DR ArrayExpress; O08807; -. DR Bgee; O08807; -. DR CleanEx; MM_PRDX4; -. DR GermOnline; ENSMUSG00000025289; Mus musculus. DR GO; GO:0005739; C:mitochondrion; IDA:MGI. DR GO; GO:0051920; F:peroxiredoxin activity; IEA:EC. DR GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR InterPro; IPR000866; Alkyl_hydroperoxide_Rdtase. DR InterPro; IPR019479; Peroxiredoxin_C. DR InterPro; IPR017936; Thioredoxin-like. DR InterPro; IPR012335; Thioredoxin_fold. DR Gene3D; G3DSA:3.40.30.10; Thioredoxin_fold; 1. DR Pfam; PF10417; 1-cysPrx_C; 1. DR Pfam; PF00578; AhpC-TSA; 1. DR PROSITE; PS51352; THIOREDOXIN_2; 1. PE 1: Evidence at protein level; KW Antioxidant; Cytoplasm; Direct protein sequencing; Disulfide bond; KW Oxidoreductase; Peroxidase; Redox-active center. FT CHAIN 1 274 Peroxiredoxin-4. FT /FTId=PRO_0000135099. FT DOMAIN 82 240 Thioredoxin. FT ACT_SITE 127 127 Cysteine sulfenic acid (-SOH) FT intermediate (By similarity). FT DISULFID 127 127 Interchain (with C-248); in linked form FT (By similarity). FT DISULFID 248 248 Interchain (with C-127); in linked form FT (By similarity). SQ SEQUENCE 274 AA; 31053 MW; 73DB5374EC46241C CRC64; MEARSKLLDG TTASRRWTRK LVLLLPPLLL FLLRTESLQG LESDERFRTR ENECHFYAGG QVYPGEASRV SVADHSLHLS KAKISKPAPY WEGTAVINGE FKELKLTDYR GKYLVFFFYP LDFTFVCPTE IIAFGDRIEE FKSINTEVVA CSVDSQFTHL AWINTPRRQG GLGPIRIPLL SDLNHQISKD YGVYLEDSGH TLRGLFIIDD KGVLRQITLN DLPVGRSVDE TLRLVQAFQY TDKHGEVCPA GWKPGSETII PDPAGKLKYF DKLN //